Research and innovation
the future of testing with a dedicated hub
This division brings together advanced expertise in physiology, cell biology, and microbiology, leveraging the synergy of these disciplines through the continuous integration of emerging techniques and technologies. Our research scope extends beyond the biocompatibility of medical devices, chemicals, pharmaceuticals, and cosmetics to encompass microbiological safety assurance.
Our scientific excellence is reflected in successful responses to public calls for proposals, peer-reviewed publications, and presentations at national and international conferences, as well as collaborations with both industrial and academic partners.
Research & Innovation Themes
Our R&I activities are structured around two main pillars:
- Development of alternative methods related to the biocompatibility of medical devices and chemicals (aligned with the 3Rs principle)
- Advancement of greener decontamination techniques
Awarded Projects Since 2021
We have been selected for four competitive research programs:
- SHIVA Program (EASY POC) – in partnership with CEA LETI
- HumSkin 3DCELL Program – in collaboration with Cherry Biotech
- INCREASE Joint Research Laboratory (LabCom) – in partnership with IBMC CNRS Strasbourg
- ENVOL Program – in partnership with MGA MedTech and LBTI CNRS, University of Lyon I
As part of our research efforts, we also benefit from a CIFRE industrial research fellowship (ANRT grant), supporting the development of our alternative methodologies.
White Paper of the French Organoids and Organ-on-Chip Sector
The result of a collective effort led by the Strategic Committee for the Health Industries and Technologies Sector, the French Organoids and Organ‑on‑Chip Sector (F3OCI) is today publishing its 2025 White Paper: an ambitious roadmap designed to structure this strategic French sector dedicated to human, animal, and environmental health.
This reference document provides an unprecedented overview of the 133 identified French projects and of the public and private stakeholders involved in the research, development, and production of organoids and organs‑on‑chip.
This white paper is published by the French Organoids and Organ‑on‑Chip Sector, co‑led by BioValley France and NETRI for France Biotech, in collaboration with CNRS, CEA, CEVA SANTE ANIMALE, ICARE*, Inserm.
Elected representatives
The Research Council deliberates on the proposals submitted by the Executive Board concerning UCA’s scientific policy. The Research Council carries out all the missions set out in Section II of Article L. 712‑6‑1 of the French Education Code.
Professor Edith Filaire has been elected to the Research Council, appointed in her own capacity as a representative of the socio‑economic sector.
The Common Interest Groups (GICs) aim to bring together manufacturers and suppliers from the pharmaceutical and bioproduction sectors in order to share practices and address key questions. An A3P GIC is expected to advance the issues raised. The members of the GIC carry out collaborative work on a shared theme and present their findings during an A3P event or through publications (the magazine La Vague, scientific and technical guides, etc.).
Christian Poinsot, PhD, and Professor Edith Filaire are members of A3P GICs (respectively the Microbiology Laboratory GIC and the Barrier Technology Group).
